How AI Is Turning a Six-Week Wait for a Cancer Diagnosis Into One Day

Artificial intelligence is starting to change breast cancer care before treatment even begins.

Researchers at UCSF and UC Berkeley used an AI model called Mirai to identify women at high risk immediately after screening mammography and move them into expedited diagnostic evaluation.

The workflow reduced diagnostic assessment from weeks to about one hour. Among women diagnosed with breast cancer, the median time to biopsy fell from more than two months to fewer than ten days.

AI changed the workflow, not the diagnosis

Mirai was trained on hundreds of thousands of mammograms linked to clinical outcomes.

In a prospective implementation at Zuckerberg San Francisco General Hospital, the model analyzed 4,100 screening mammograms and identified 525 women for immediate follow-up.

The AI did not diagnose cancer or replace the radiologist. It prioritized patients most likely to benefit from rapid assessment, allowing imaging, specialist review, and biopsy to begin sooner.

A new role for AI in cancer care

Most discussions about medical AI focus on diagnostic accuracy.

This study highlights a different application: workflow optimization. By identifying high-risk patients earlier, AI reduced delays without changing who makes the clinical decision.

For breast surgeons and multidisciplinary cancer teams, that could mean earlier referrals, faster treatment planning, and less time between screening and definitive care.

Beyond breast imaging

The same approach could extend beyond mammography.

As AI becomes integrated into clinical workflows, its greatest impact may be identifying patients who need immediate attention rather than interpreting images alone.

Why It Matters

The first measurable benefit of medical AI may not be better diagnoses. It may be getting patients to the right specialist faster.

Source: npj Digital Medicine